OutPerformDaily

  • Tech Stocks
  • Cannabis Stocks
  • Index Funds
  • International
  • Short
  • Stock Picks

Lost Password?

Top 3 AI Stocks to Invest in Right Now

Fake shopping sprees and ‘happiness insurance’: The latest fintech apps reveal our financial anxieties

Is Apple’s foldable iPhone Duo worth $2,000? See how it stacks up against other foldable phones.

I gave my HomeExchange guest a 5-star review. Then I found heat marks all over my dining table. Do I call her out?

Inside the push to weaken Washington’s toughest financial watchdog

Scared to spend your retirement money? Here’s one way to get over the fear of running out.

OutPerformDaily
  • Tech Stocks
  • Cannabis Stocks
  • Index Funds
  • International
  • Short
  • Stock Picks
OutPerformDaily
  • Tech Stocks
  • Cannabis Stocks
  • Index Funds
  • International
  • Short
  • Stock Picks
3rdPartyFeeds

What the Latest Updates Mean for AMD and Nvidia Stock Investors

December 27, 2022

Today's video focuses on Advanced Micro Devices (NASDAQ: AMD) and Nvidia (NASDAQ: NVDA) and recent updates that semiconductor investors should be aware of for...

3rdPartyFeeds

Buy shares of only the strongest companies to make money in 2023, including ‘the kings of cash flow,’ says this five-star fund manager

December 27, 2022

The worst may be over for the stock market for this cycle, but many economists see more pain ahead for 2023, including a possible recession that will create...

3rdPartyFeeds

3 Reasons Amazon Stock Could Soar in 2023

December 27, 2022

It's been an agonizing year for Amazon's (NASDAQ: AMZN) shareholders. Following several quarters of slowing growth, Amazon's shares are down a brutal 49% year...

3rdPartyFeeds • News

Futures Movers: Oil prices boosted by China optimism, U.S. winter storm

December 27, 2022

Oil futures rise Tuesday, lifted by optimism over Chinese demand and as cold weather forced the shutdown of several Texas refineries.
Read More...

3rdPartyFeeds • News

The Wall Street Journal: Over-the-counter overdose-reversal drug from nonprofit pharma group wins fast-track U.S. review

December 27, 2022

Harm Reduction Therapeutics says it plans to produce 2 million doses of 3-milligram naloxone nasal spray, called Rivive, per year.
Read More...

3rdPartyFeeds

Investors Get These 3 Things Wrong When It Comes to Amazon Stock

December 27, 2022

Amazon's (NASDAQ: AMZN) stock is an anomaly in many respects. Its approximate $850 billion market cap often implies slow growth ahead, but Amazon has typically...

3rdPartyFeeds

Tesla market cap set to fall below Walmart and JPMorgan Chase, to sit just above Nvidia

December 27, 2022

Another selloff in Tesla Inc.’s stock (TSLA) on Tuesday, toward a more than two-year low, could drop the electric vehicle maker down to 13th on the list of...

3rdPartyFeeds

Should You Sign Up for Netflix Once Password Sharing Comes to an End?

December 27, 2022

Netflix has long allowed users to share passwords. Although the details aren't perfectly clear yet, it's likely Netflix will continue allowing people within...

3rdPartyFeeds

3 Compelling Cybersecurity Stocks That Could Soar in 2023

December 27, 2022

Google parent company Alphabet (NASDAQ: GOOG)(NASDAQ: GOOGL), Palo Alto Networks (NASDAQ: PANW), and CrowdStrike (NASDAQ: CRWD) are on the front lines and have...

3rdPartyFeeds • News

Real Retirement: This accidental influencer became a role model with middle-aged dad advice

December 27, 2022

Social media influencer Joe Buckner has created a following by offering classic lessons a dad would often teach.
Read More...

Previous 1 … 1,856 1,857 1,858 1,859 1,860 … 8,455 Next
Indices by TradingView

Top 3 AI Stocks to Invest in Right Now

October 18, 2026

Categories

  • 3rdPartyFeeds
  • Cannabis Stocks
  • Index Funds
  • International
  • News
  • Short
  • Stock Picks
  • Tech Stocks
  • Uncategorized
Indices by TradingView
While subscribers receive the benefit of Outperformdaily opinions, none of the information contained therein constitutes a recommendation from Outperformdaily that any particular security, portfolio of securities, transaction, option, or investment strategy is suitable for any specific person. You further understand that we will not advise you personally concerning the nature, potential, value or suitability of any particular security, portfolio of securities, transaction, investment strategy or other matter. To the extent any of the information contained in Outperformdaily may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person. Outperformdaily’s past results are not necessarily indicative of future performance. All investments are subject to loss. Our employees and writters typically personally invest in all recommendations, but they are not obligated too. Our employees and writters are prohibited from taking an opposite position from which they write about.